alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 312
Editorial Note: Nomenclature changes to part 312 appear at 69 FR 13717, Mar. 24, 2004.

§ 312.20 Requirement for an IND. ( a ) A sponsor shall submit an IND to FDA if the sponsor intends to conduct a clinical investigation with an investigational new drug that is subject to § 312.2(a).
( b ) A sponsor shall not begin a clinical investigation subject to § 312.2(a) until the investigation is subject to an IND which is in effect in accordance with § 312.40.
( c ) A sponsor shall submit a separate IND for any clinical investigation involving an exception from informed consent under § 50.24 of this chapter. Such a clinical investigation is not permitted to proceed without the prior written authorization from FDA. FDA shall provide a written determination 30 days after FDA receives the IND or earlier.
[52 FR 8831, Mar. 19, 1987, as amended at 61 FR 51529, Oct. 2, 1996; 62 FR 32479, June 16, 1997]
```

[Federal Register Volume 79, Number 186 (Thursday, September 25, 2014)]
[Notices]
[Page 57579]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22774]

-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Advisory Committee on Increasing Competitive Integrated 
Employment for Individuals With Disabilities

AGENY: Office of Disability Employment Policy, U.S. Department of 
Labor.

ACTION: Notice; Correction.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of Labor, Office of Disability Employment 
Policy published a document in the Federal Register of September 12, 
2014, inviting interested parties to submit nominations for individuals 
to serve on the Advisory Committee on Increasing Competitive Integrated 
Employment for Individuals with Disabilities. The document failed to 
provide the email address to submit nominations under the heading, 
``ADDRESSES, Electronically, in column 3 on page 54746. However, the 
email address, IntegratedCompetitiveEmployment@dol.gov, was provided in 
column 2 on page 54746.

FOR FURTHER INFORMATION CONTACT: Christopher Button, 202-693-7880
    Correction:
    In the Federal Register of September 12, 2014, in FR Doc. 2014-
21834, on page 54746, under the heading, ADDRESSES, Electronically, in 
column 3, remove the words, ``INSERT EMAIL ADDRESS FOR COMMITTEE,'' and 
replace with ``IntegratedCompetitiveEmployment@dol.gov.''

    Dated: September 18, 2014.
Jennifer Sheehy,
Deputy Assistant Secretary, Office of Disability Employment Policy.
[FR Doc. 2014-22774 Filed 9-24-14; 8:45 am]
BILLING CODE 4510-23-P
```
# C_2014253EN.01001802.xml

| 4.8.2014 | EN | Official Journal of the European Union | C 253/18 |
| --- | --- | --- | --- |

4.8.2014

EN

Official Journal of the European Union

C 253/18

---

Request for a preliminary ruling from the Conseil d’État (France) lodged on 26 May 2014 — Air France — KLM v Ministère des finances et des comptes publics

(Case C-250/14)

2014/C 253/24

Language of the case: French

Referring court

Referring court

Conseil d’État

Parties to the main proceedings

Parties to the main proceedings

Applicant: Air France — KLM

Applicant:

Defendant: Ministère des finances et des comptes publics

Defendant:

Questions referred

Questions referred

| 1. | Must Articles 2(1) and 10(2) of Council Directive 77/388/EEC of 17 May 1977 (1) be interpreted as meaning that the issue of the ticket may be treated as the effective performance of the transport service and that the sums retained by an airline company where the holder of an air ticket has not used his ticket, which is no longer valid, are subject to value added tax? |
| --- | --- |

1.

Must Articles 2(1) and 10(2) of Council Directive 77/388/EEC of 17 May 1977 (1) be interpreted as meaning that the issue of the ticket may be treated as the effective performance of the transport service and that the sums retained by an airline company where the holder of an air ticket has not used his ticket, which is no longer valid, are subject to value added tax?

1

| 2. | In that case, must the tax received be paid onwards to the Treasury on receipt of payment of the price, even though the travel may not have taken place as a result of the customer’s acts? |
| --- | --- |

2.

In that case, must the tax received be paid onwards to the Treasury on receipt of payment of the price, even though the travel may not have taken place as a result of the customer’s acts?

---

(1)  Sixth Council Directive 77/388/EEC of 17 May 1977 on the harmonization of the laws of the Member States relating to turnover taxes — Common system of value added tax: uniform basis of assessment (OJ 1977 L 145, p. 1).

1

---
I 

118TH CONGRESS 

2D SESSION H. R. 7564 

To amend the Justice for United States Victims of State Sponsored Terrorism 

Act with respect to certain victims. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 6, 2024 

Mr. GAETZ introduced the following bill; which was referred to the Committee 

on the Judiciary 

A BILL 

To amend the Justice for United States Victims of State 

Sponsored Terrorism Act with respect to certain victims. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. IMPROVEMENTS TO THE JUSTICE FOR UNITED 

4 STATES VICTIMS OF STATE SPONSORED TER5 RORISM ACT. 

6 Section 404(d)(4)(D)(i) of the Justice for United 

7 States Victims of State Sponsored Terrorism Act (34 

8 U.S.C. 20144(d)(4)(D)(i)) is amended— 

9 (1) by striking ‘‘Not later than 1 year’’ and in10 serting the following: 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7564 IH

1 ‘‘(I) AUDIT.—Not later than 1 

2 year’’; and 

3 (2) by adding at the end the following: 

4 ‘‘(II) CATCH-UP PAYMENTS.— 

5 ‘‘(aa) IN GENERAL.—A 

6 1983 Beirut barracks bombing 

7 victim or a 1996 Khobar Towers 

8 bombing victim who has had a 

9 final judgment issued before De10 cember 29, 2022, and had an ap11 plication accepted by the Fund 

12 before December 29, 2022, but 

13 missed one or more of the four 

14 rounds of payments issued by the 

15 Fund, shall be eligible for a 

16 lump-sum catch-up payment, cal17 culated with the same method18 ology used for 1983 Beirut bar19 racks bombing victims and 1996 

20 Khobar Towers bombing victims 

21 deemed eligible under the Fair22 ness for 9/11 Families Act, but 

23 adjusted for any prior payment 

24 from the first four rounds. 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7564 IH

1 ‘‘(bb) AUDIT.—Not later 

2 than 30 days after the date of 

3 this subclause, the Comptroller 

4 General of the United States 

5 shall conduct an audit and pub6 lish in the Federal Register a no7 tice of proposed lump sum catch8 up payments to a 1983 Beirut 

9 barracks bombing victim or a 

10 1996 Khobar Towers bombing 

11 victim eligible pursuant to item 

12 (aa).’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
# C_2016027EN.01004201.xml

| 25.1.2016 | EN | Official Journal of the European Union | C 27/42 |
| --- | --- | --- | --- |

25.1.2016

EN

Official Journal of the European Union

C 27/42

---

Judgment of the General Court of 26 November 2015 — Demp v OHIM (TURBO DRILL)

(Case T-50/14) (1)

1

((Community trade mark - Application for Community word mark TURBO DRILL - Absolute grounds for refusal - Descriptive character - Article 7(1)(c) of Regulation (EC) No 207/2009))

(2016/C 027/50)

Language of the case: German

Parties

Parties

Applicant: Demp BV (Vianen, Netherlands) (represented by: C. Gehweiler, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: A. Schifko, Agent)

Defendant:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 22 November 2013 (Case R 1254/2013-4), concerning an application for registration of the word sign TURBO DRILL as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Demp BV to pay the costs. |
| --- | --- |

2.

Orders Demp BV to pay the costs.

---

(1)  OJ C 78, 15.3.2014.

1

---
§ 133.168 Pasteurized blended cheese with fruits, vegetables, or meats. ( a ) Pasteurized blended cheese with fruits, vegetables, or meats, or mixtures of these is the food which conforms to the definition and standard of identity, and is subject to the requirements for label statement of ingredients, prescribed for pasteurized blended cheese by § 133.167, except that: ( 1 ) Its moisture content may be 1 percent more, and the milk fat content of its solids may be 1 percent less, than the limits prescribed by § 133.167 for moisture and milk fat in the corresponding pasteurized blended cheese.
( 2 ) It contains one or any mixture of two or more of the following: Any properly prepared cooked, canned, or dried fruit; any properly prepared cooked, canned, or dried vegetable; any properly prepared cooked or canned meat.
( 3 ) When the added fruits, vegetables, or meats contain fat, the method prescribed for the determination of fat by § 133.5(b) is not applicable.
( b ) The name of a pasteurized blended cheese with fruits, vegetables, or meats is the name prescribed by § 133.167 for the applicable pasteurized blended cheese, followed by the term “with ______”, the blank being filled in with the common or usual name or names of the fruits, vegetables, or meats used, in order of predominance by weight.
[42 FR 14366, Mar. 15, 1977, as amended at 49 FR 10095, Mar. 19, 1977; 58 FR 2894, Jan. 6, 1993]
# C_2014175EN.01002601.xml

| 10.6.2014 | EN | Official Journal of the European Union | C 175/26 |
| --- | --- | --- | --- |

10.6.2014

EN

Official Journal of the European Union

C 175/26

---

Action brought on 21 March 2014 — European Commission v Council of the European Union

(Case C-134/14)

2014/C 175/32

Language of the case: French

Parties

Parties

Applicant: European Commission (represented by: R. Lyal, W. Mölls, and D. Martin, acting as Agents)

Applicant:

Defendant: Council of the European Union

Defendant:

Form of order sought

Form of order sought

| — | Annul Council Directive 2013/62/EU of 17 December 2013 amending Directive 2010/18/EU implementing the revised Framework Agreement on parental leave concluded by BUSINESSEUROPE, UEAPME, CEEP and ETUC, following the amendment of the status of Mayotte with regard to the European Union (1); |
| --- | --- |

—

Annul Council Directive 2013/62/EU of 17 December 2013 amending Directive 2010/18/EU implementing the revised Framework Agreement on parental leave concluded by BUSINESSEUROPE, UEAPME, CEEP and ETUC, following the amendment of the status of Mayotte with regard to the European Union (1);

1

| — | Maintain the effects of Directive 2013/62/EU until such time as a new directive founded on an appropriate legal basis enters into effect; |
| --- | --- |

—

Maintain the effects of Directive 2013/62/EU until such time as a new directive founded on an appropriate legal basis enters into effect;

| — | Order the Council of the European Union to pay the costs. |
| --- | --- |

—

Order the Council of the European Union to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

The Commission seeks the annulment of Directive 2013/62/EU, which the Council adopted on the legal basis of Article 349 TFEU.

The Commission alleges that the Council adopted that directive when it had proposed to base that act on a sectoral legal basis, namely Article 155(2) TFEU.

It considers that, in accordance with the purpose and aim of the contested directive, Article 349 TFEU cannot validly be used as a legal basis. Article 349 TFEU only applies when derogating from the principle of the application of primary law to the outermost regions, as established in Article 355(1) TFEU. However, the directive in question, if it is not to derogate from the Treaties, only adapts the secondary law in order to respond to the situation created by the change in status of Mayotte. That interpretation is supported not only by the wording of Article 349 TFEU, but also by the system of legal bases of the Treaty and by the historical origins of that article.

---

(1)  OJ 2013 L 353, p. 7.

1

---
§ 582.1366 Hydrogen peroxide. ( a ) *Product.* Hydrogen peroxide.
( b ) [Reserved]
( c ) *Limitations, restrictions, or explanation.* This substance is generally recognized as safe when used as a bleaching agent in accordance with good manufacturing or feeding practice.
FILED

January 31, 1996

Cecil Crowson, Jr.

Appellate Court Clerk

IN THE COURT OF CRIMINAL APPEALS OF TENNESSEE

AT JACKSON

NOVEMBER 1995 SESSION

STATE OF TENNESSEE, ) NO. 02C01-9506-CC-00178

)

Appellee ) HARDEMAN COUNTY

)

V. ) HON. JON KERRY BLACKWOOD

) JUDGE

CHAD DOUGLAS POOLE, )

) (Sentencing)

Appellant )

CONCURRING OPINION 

Like Judge Summers, I fully agree with the conclusion and rationale

expressed in the opinion written by Judge Welles. Based upon the record in this case

and our Supreme Court's opinion in State v. Adams, 864 S.W.2d 31 (Tenn. 1993), the

"particularly vulnerable" enhancement factor was not shown to be applicable in this

case. In State v. Adams, Justice Drowota, writing for a unanimous Court, stated:

The factor can be used . . . if the circumstances show that

the victim, because of his age or physical or mental

condition, was in fact "particularly vulnerable," i.e.,

incapable of resisting, summoning help, or testifying

against the perpetrator. 

State v. Adams, at 35.

As pointed out by Judge Summers, the youngest victim in Adams was four

years old, but the Court found that the child's age, standing alone, was insufficient

evidence of his being "particularly vulnerable." 

In the present case, the victim was a seventy-one-year-old female and her

assailant was assisted by the appellant, a twenty-one-year-old male. The elderly

victim was attacked with a baseball bat by surprise when she entered her home and

found the appellant and his co-defendant lying in wait for her. 

Perhaps our Supreme Court will take this opportunity to furnish guidance for

lower courts and the bar in properly applying State v. Adams in the future. 
2

 

WILLIAM M. BARKER, JUDGE
<PAGE>

                                                                      Exhibit 99

                    Certification of CEO and CFO Pursuant to
                             18 U.S.C. Section 1350,
                             as Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Prandium, Inc. (the
"Company") for the quarterly period ended June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), Kevin S.
Relyea, as Chief Executive Officer of the Company, and Robert T. Trebing, Jr.,
as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18
U.S.C. (S) 1350, as adopted pursuant to (S) 906 of the Sarbanes-Oxley Act of
2002, that, to the best of his knowledge:

     (1)  The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

/s/ Kevin S. Relyea
Name: Kevin S. Relyea
Title: Chief Executive Officer
Date:  August 14, 2002

/s/ Robert T. Trebing, Jr.
Name: Robert T. Trebing, Jr.
Title: Chief Financial Officer
Date:  August 14, 2002

This certification accompanies the Report pursuant to (S) 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of (S)
18 of the Securities Exchange Act of 1934, as amended.
§ 524.660 Dimethyl sulfoxide. ( a ) *Specifications.* ( 1 ) Each milliliter (mL) of solution contains 90 percent dimethyl sulfoxide and 10 percent water.
( 2 ) Each milliliter (mL) of gel product contains 90 percent dimethyl sulfoxide.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in horses and dogs* — ( 1 ) *Amount* — ( i ) *Horses.* Apply topically two to three times daily in an amount not to exceed 100 mL per day. Total duration of therapy should not exceed 30 days.
( ii ) *Dogs.* Apply topically three to four times daily in an amount not to exceed 20 mL per day. Total duration of therapy should not exceed 14 days.
( 2 ) *Indications for use.* To reduce acute swelling due to trauma.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 10967, Feb. 27, 2014]
I 

118TH CONGRESS 

2D SESSION H. R. 7441 

To amend part A of title IV of the Social Security Act to set aside funds 

expended under the program of block grants to States for temporary 

assistance for needy families, for core work purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 23, 2024 

Mr. MOORE of Utah introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To amend part A of title IV of the Social Security Act 

to set aside funds expended under the program of block 

grants to States for temporary assistance for needy families, for core work purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Restoring Temporary 

5 to TANF Act’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7441 IH

1 SEC. 2. SET-ASIDE OF FUNDS FOR CORE WORK PURPOSES. 

2 (a) IN GENERAL.—Section 408(a) of the Social Secu3 rity Act (42 U.S.C. 608(a)) is amended by adding at the 

4 end the following: 

5 ‘‘(13) REQUIREMENT TO EXPEND FUNDS FOR

6 CORE WORK ACTIVITIES.—A State to which a grant 

7 is made under section 403(a)(1) for a fiscal year 

8 shall expend not less than 25 percent of the grant 

9 amount on work supports, education and training, 

10 apprenticeships, non-recurring short term benefits, 

11 work activities (as defined in section 407(d)), and 

12 case management needed to assist individuals with 

13 developing an individual responsibility plan pursuant 

14 to subsection (b) of this section.’’. 

15 (b) EFFECTIVE DATE.—The amendment made by 

16 subsection (a) shall take effect on October 1, 2025. 

17 SEC. 3. TWO-YEAR REAUTHORIZATION OF THE TEMPORARY 

18 ASSISTANCE FOR NEEDY FAMILIES PRO19 GRAM. 

20 Activities authorized by part A of title IV (other than 

21 under section 403(c) or 418) and section 1108(b) of the 

22 Social Security Act shall continue through September 30, 

23 2026, in the manner authorized for fiscal year 2023, and 

24 out of any money in the Treasury of the United States 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7441 IH

1 not otherwise appropriated, there are hereby appropriated 

2 such sums as may be necessary for such purpose. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

Y.D., the Mother, and

T.C., the Father,

Appellants,

v.

DEPARTMENT OF CHILDREN AND FAMILIES, and

STATEWIDE GUARDIAN AD LITEM OFFICE,

Appellees.

Nos. 4D23-182 and 4D23-279

[June 15, 2023]

Consolidated appeals from the Circuit Court for the Fifteenth Judicial 

Circuit, Palm Beach County; Roger B. Colton, Senior Judge; L.T. Case No. 

50-2020-DP-000839-XXXX-MB.

Ilene F. Tuckfield of Ilene F. Tuckfield, P.A., Coral Gables, for appellant 

Y.D., the Mother.

Andrew A. Holness of the Law Offices of Andrew A. Holness, P.A., West 

Palm Beach, for appellant T.C., the Father.

Andrew Feigenbaum of Children’s Legal Services, West Palm Beach, for 

appellee Department of Children and Families.

Sara Elizabeth Goldfarb, Statewide Director of Appeals, and Sarah Todd 

Weitz, Senior Attorney, Appellate Division of the Statewide Guardian ad 

Litem Office, Tallahassee, for appellee Statewide Guardian ad Litem Office.

PER CURIAM.

Affirmed.

WARNER, MAY and GERBER, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
    This schedule contains summary financial information extracted from Balance 
Sheet at 3/31/97, Statements of Operations as of 3/31/97 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<CIK>                         0000814055
<NAME>                        You Bet International
<MULTIPLIER>                    0
<CURRENCY>                      0
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>               DEC-31-1997
<PERIOD-START>                  JAN-01-1997
<PERIOD-END>                    MAR-31-1997
<EXCHANGE-RATE>                 1
<CASH>                          6,000
<SECURITIES>                    0
<RECEIVABLES>                   7,000
<ALLOWANCES>                    0
<INVENTORY>                     0
<CURRENT-ASSETS>                158,000
<PP&E>                          935,000
<DEPRECIATION>                  0
<TOTAL-ASSETS>                  1,148,000
<CURRENT-LIABILITIES>           2,513,000
<BONDS>                         0
<PREFERRED-MANDATORY>           0
<PREFERRED>                     0
<COMMON>                        8,000
<OTHER-SE>                      (1,508,000)
<TOTAL-LIABILITY-AND-EQUITY>    1,148,000
<SALES>                         2,000
<TOTAL-REVENUES>                0
<CGS>                           0
<TOTAL-COSTS>                   1,088,000
<OTHER-EXPENSES>                0
<LOSS-PROVISION>               (1,120,000)
<INTEREST-EXPENSE>             (34,000)
<INCOME-PRETAX>                 0
<INCOME-TAX>                    0
<INCOME-CONTINUING>             0
<DISCONTINUED>                  0
<EXTRAORDINARY>                 0
<CHANGES>                       0
<NET-INCOME>                    (1,120,000)
<EPS-PRIMARY>                   (0.14)
<EPS-DILUTED>                   0
        


</TABLE>
§ 524.1600b Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment. ( a ) *Specifications.* Each cubic centimeter of ointment contains: 100,000 units of nystatin, neomycin sulfate equivalent to 2.5 milligrams of neomycin base, 2,500 units of thiostrepton, and 1.0 milligram of triamcinolone acetonide.
( b ) *Sponsor.* See No. 053501 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See §§ 556.430 and 556.470 of this chapter.
( d ) *Conditions of use* — ( 1 ) *Dogs and cats* — ( i ) *Amount.* Apply 1 drop of ointment to the affected eye(s) 2 or 3 times daily. Treatment may be continued for up to 2 weeks if necessary.
( ii ) *Indications for use.* For use as an anti-inflammatory, antipruritic, antifungal (*Candida albicans*), and antibacterial ointment for local therapy in keratitis and conjunctivitis.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Cattle* — ( i ) *Amount.* Apply small line of ointment to the affected eye(s) once daily. Treatment may be continued for up to 2 weeks if necessary.
( ii ) *Indications for use.* For infectious kerato-conjunctivitis (pinkeye).
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[40 FR 13873, Mar. 27, 1975, as amended at 50 FR 41490, Oct. 11, 1985; 79 FR 10972, Feb. 27, 2014; 84 FR 32993, July 11, 2019]
#### § 640.125 Definitions.

The definitions set out in § 630.3 of this chapter apply to the use of those defined terms in this part.